A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
Journal
Targeted Oncology
Journal Volume
17
Journal Issue
1
Pages
15-24
Date Issued
2022
Author(s)
Shimizu T.
Kuboki Y.
Yonemori K.
Yanai T.
Faller D.V.
Dobler L.
Gupta N.
Sedarati F.
Kim K.-P.
Publisher
Adis
Type
journal article